MentionFox
Home › funding signals › US KIDNEY RESEARCH Corp
Form D · on the record

US KIDNEY RESEARCH Corp — $475K Form D filing, August 2026

US KIDNEY RESEARCH Corp filed a Form D with the Securities and Exchange Commission on 2026-08-06.

US KIDNEY RESEARCH Corp filed a Form D notice of an exempt securities offering with the SEC on August 6, 2026. The filing reports $475K sold. Its industry group is Other Health Care. It names Roland Ludlow (Executive Officer) (SEC Form D, August 6, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Other Health Care raises in California, August 2026 ↓

Is this your company?

Key facts

Run the free check on US KIDNEY RESEARCH Corp →

Sell to companies like US KIDNEY RESEARCH Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

US KIDNEY RESEARCH Corp

New Form D on file · 2026-08-06 · the record

$475K
raise on the record
D
filing
2
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-08-06
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
BasedROSEVILLE, CALIFORNIA
CIK1652707
Accession0001652707-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns US KIDNEY RESEARCH Corp.

Free to see. No signup.

Keep reading

More on the people and the money behind US KIDNEY RESEARCH Corp, from the filings we hold.

More raises like this

Other Health Care raises by companies based in California, filed in August 2026, largest first.

What do you want to do with US KIDNEY RESEARCH Corp?

Get the full cited report on US KIDNEY RESEARCH Corp

What the filing shows about US KIDNEY RESEARCH Corp

  • 2 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on US KIDNEY RESEARCH Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives US KIDNEY RESEARCH Corp's address as 2306 Thistle Down Drive, Roseville, CA 95661.

What the filing says

  • Offered: $474,999. Sold: $474,999. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 2 had already invested. (filing)
  • Date of first sale: January 9, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on US KIDNEY RESEARCH Corp See pricing

Is US KIDNEY RESEARCH Corp a real, registered company?

US KIDNEY RESEARCH Corp is a registered filer with the SEC (CIK 1652707) and has filed since 2023-01-18. 3 filings are on record, the latest on 2026-08-06.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs US KIDNEY RESEARCH Corp?

US KIDNEY RESEARCH Corp's Form D of 2026-08-06 names Roland Ludlow as its officers, directors or promoters.

How much has US KIDNEY RESEARCH Corp raised?

Its new offerings report $3.29M sold across 3 offerings, as its own filings state.

Filing history · 7 filings on this registrant
Form D · 2023-01-18 · $1.50MForm D · 2024-10-23 · $1.32MForm D/A, amended · 2024-11-22 · $4.69MForm D/A, amended · 2024-11-22 · $1.32MForm D/A, amended · 2025-01-30 · $1.50MForm D/A, amended · 2025-01-30 · $475KForm D · 2026-08-06 · $475K · this page 2023-01-18 2026-08-06

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Other Health Care · by week
This raise, $475K, filed week of Aug 3

Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $475K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on US KIDNEY RESEARCH Corp?

What the filing shows about US KIDNEY RESEARCH Corp

  • 2 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on US KIDNEY RESEARCH Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on US KIDNEY RESEARCH Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind US KIDNEY RESEARCH Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (uskidneyresearchcorp.com).

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for US KIDNEY RESEARCH Corp. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

US KIDNEY RESEARCH Corp: Raised $475K, Form D filed 2026-08-06
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/us-kidney-research-corp-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
US KIDNEY RESEARCH Corp raised $475K — SEC Form D filing, August 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/us-kidney-research-corp-form-d-26000001